Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

IPO Update: Will Declining Returns Slow Fast Pace Of Biopharma Offerings?

Apr 03 2018

• By Mandy Jackson

stock

Related Content

Finance Watch: NDA-Ready Impact Gets Commitment For Another $90m

Oct 30 2017

Mereo On The Move With Strong COPD Data And US Listing Plan

Dec 18 2017

Novartis Bolsters I-O Discovery Pipeline With Surface Oncology Deal

Jan 12 2016

ASLAN Firms Up IPO Plans As Lead Asset Progresses

Apr 27 2017

IPOs In Review: Biopharma Offerings Bounced Back In 2017 As Returns Rose

Jan 04 2018

IPO Update: Seven In January As Big Returns, Solid's Slip-Up Contribute To Bubble Concerns

Feb 02 2018

Morphosys Seeks US Listing To Cement Corporate Developments

Mar 23 2018

Asia's Nasdaq? Hong Kong‘s Quest To Be IPO Power House Has Blessings And Curses

Mar 28 2018

Finance Watch: Biopharma IPOs Defy Broader Stock Performance Trends

Mar 09 2018

Finance Watch: Despite Bad News, IPOs And Public Offerings Keep Flowing

Mar 16 2018

FUNDING ROUNDUP: One startup, six public companies raise cash

Jan 10 2015

Related Companies

Homology Medicines, Inc.

Cogent Biosciences, Inc.

Solid Biosciences Inc.

Alzheon Inc.

MorphoSys AG

Mereo BioPharma Group plc

Novartis AG

Surface Oncology, Inc.

ASLAN Pharmaceuticals

Additional Topics

Financing Business Strategies StartUps and SMEs Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window